Pasireotide: a novel treatment for patients with acromegaly

Overview of attention for article published in Drug Design, Development and Therapy, January 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 89 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,297 followers.

RT @EndocrinoHUVR: @HSauces @VenegasEva @HospitalUVRocio @alfonsosotoendo @miriamc90 @antares89 @ElenaDF75 @sociedadSEEN @justocastano @Lou…

Reply Repost Favourite

@HSauces @VenegasEva @HospitalUVRocio @alfonsosotoendo @miriamc90 @antares89 @ElenaDF75 @sociedadSEEN @justocastano @LourdesGDoncel Enviamos este artículo, Pasireotide: a novel treatment for patients with acromegaly. ⤵️ https://t.co/gWshdp9erx

Reply Repost Favourite

PASIREOTIDE a novel treatment for patients with acromegaly Authors: Cuevas-Ramos D, Fleseriu M https://t.co/wA4uuuUMeK

Reply Repost Favourite

Pasireotide in acromegaly https://t.co/9Z9F0LyX6M

Reply Repost Favourite